News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
311,857 Results
Type
Article (16588)
Company Profile (112)
Press Release (295148)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (96417)
Career Advice (509)
Deals (16708)
Drug Delivery (77)
Drug Development (41724)
Employer Resources (52)
FDA (7788)
Job Trends (6894)
News (166828)
Policy (15716)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (669)
Accelerated approval (13)
Adcomms (11)
Allergies (71)
Alliances (25155)
ALS (68)
Alzheimer's disease (577)
Antibody-drug conjugate (ADC) (146)
Approvals (8021)
Artificial intelligence (222)
Autoimmune disease (43)
Automation (13)
Bankruptcy (155)
Best Places to Work (5025)
BIOSECURE Act (9)
Biosimilars (135)
Biotechnology (45)
Bladder cancer (54)
Brain cancer (35)
Breast cancer (367)
Cancer (1933)
Cardiovascular disease (197)
Career advice (454)
Career pathing (13)
CAR-T (73)
CDC (12)
Cell therapy (202)
Cervical cancer (15)
Clinical research (36687)
Collaboration (799)
Compensation (345)
Complete response letters (37)
COVID-19 (872)
CRISPR (45)
C-suite (467)
Cystic fibrosis (66)
Data (2570)
Denatured (18)
Depression (54)
Diabetes (235)
Diagnostics (1809)
Digital health (11)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (121)
Drug pricing (117)
Drug shortages (13)
Duchenne muscular dystrophy (98)
Earnings (37428)
Editorial (23)
Employer branding (5)
Employer resources (46)
Events (44995)
Executive appointments (571)
FDA (9181)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (529)
Gene editing (78)
Generative AI (18)
Gene therapy (208)
GLP-1 (522)
Government (1595)
Grass and pollen (5)
Guidances (195)
Healthcare (4933)
HIV (15)
Huntington's disease (13)
IgA nephropathy (50)
Immunology and inflammation (82)
Immuno-oncology (18)
Indications (66)
Infectious disease (949)
Inflammatory bowel disease (106)
Inflation Reduction Act (8)
Influenza (29)
Intellectual property (126)
Interviews (65)
IPO (6501)
IRA (34)
Job creations (2118)
Job search strategy (406)
JPM (32)
Kidney cancer (10)
Labor market (28)
Layoffs (230)
Leadership (8)
Legal (3792)
Liver cancer (33)
Longevity (9)
Lung cancer (246)
Lymphoma (151)
Machine learning (17)
Management (18)
Manufacturing (429)
MASH (96)
Medical device (2980)
Medtech (2991)
Mergers & acquisitions (10658)
Metabolic disorders (628)
Multiple sclerosis (52)
NASH (14)
Neurodegenerative disease (103)
Neuropsychiatric disorders (39)
Neuroscience (1054)
Neurotech (1)
NextGen: Class of 2026 (1929)
Non-profit (916)
Now hiring (18)
Obesity (280)
Opinion (149)
Ovarian cancer (89)
Pain (124)
Pancreatic cancer (69)
Parkinson's disease (94)
Partnered (12)
Patents (255)
Patient recruitment (166)
Peanut (12)
People (32032)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase 1 (9726)
Phase 2 (15690)
Phase 3 (13691)
Pipeline (2375)
Policy (141)
Postmarket research (1516)
Preclinical (3980)
Press Release (27)
Prostate cancer (97)
Psychedelics (19)
Radiopharmaceuticals (152)
Rare diseases (392)
Real estate (2836)
Recruiting (19)
Regulatory (12348)
Reports (15)
Research institute (773)
Resumes & cover letters (63)
Rett syndrome (7)
RNA editing (6)
RSV (25)
Schizophrenia (76)
Series A (92)
Series B (60)
Service/supplier (3)
Sickle cell disease (52)
Special edition (10)
Spinal muscular atrophy (82)
Sponsored (12)
Startups (1797)
State (2)
Stomach cancer (8)
Supply chain (55)
Tariffs (69)
The Weekly (45)
Vaccines (275)
Venture capital (33)
Weight loss (176)
Women's health (43)
Worklife (4)
Date
Last 7 days (217)
Last 30 days (846)
Last 365 days (12639)
2026 (1129)
2025 (12974)
2024 (14861)
2023 (16850)
2022 (22652)
2021 (23231)
2020 (21950)
2019 (17648)
2018 (13788)
2017 (15778)
2016 (14831)
2015 (17469)
2014 (13906)
2013 (11682)
2012 (12668)
2011 (13223)
2010 (12142)
Location
Africa (332)
Alabama (21)
Alaska (2)
Arizona (96)
Arkansas (4)
Asia (22897)
Australia (3092)
California (4077)
Canada (1649)
China (617)
Colorado (156)
Connecticut (176)
Delaware (168)
Europe (45631)
Florida (698)
Georgia (125)
Hawaii (2)
Idaho (14)
Illinois (393)
India (46)
Indiana (278)
Iowa (2)
Japan (291)
Kansas (80)
Kentucky (21)
Louisiana (5)
Maine (2)
Maryland (499)
Massachusetts (3126)
Michigan (67)
Minnesota (222)
Mississippi (1)
Missouri (71)
Montana (8)
Nebraska (8)
Nevada (29)
New Hampshire (12)
New Jersey (1633)
New Mexico (9)
New York (1103)
North Carolina (667)
North Dakota (4)
Northern California (1882)
Ohio (95)
Oklahoma (6)
Oregon (21)
Pennsylvania (871)
Puerto Rico (14)
Rhode Island (19)
South America (547)
South Carolina (11)
Southern California (1724)
Tennessee (61)
Texas (571)
United States (15524)
Utah (101)
Virginia (170)
Washington D.C. (44)
Washington State (290)
West Virginia (2)
Wisconsin (43)
Wyoming (1)
311,857 Results for "endo pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
Both Mallinckrodt and Endo have previously declared bankruptcy, linked to opioid-related lawsuits.
March 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Amylyx Pharmaceuticals to Host Event to Discuss Post-bariatric Hypoglycemia and Avexitide at ENDO 2025
July 9, 2025
·
8 min read
Press Releases
Endo Announces Peyronie’s Disease Presentation at the North Central Section of the American Urological Association
October 16, 2025
·
9 min read
Press Releases
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
July 14, 2025
·
12 min read
Press Releases
Mallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals Leader
June 16, 2025
·
13 min read
Press Releases
Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States
October 21, 2025
·
8 min read
Press Releases
Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025
June 25, 2025
·
8 min read
Press Releases
Endo Announces Divestiture of International Pharmaceuticals Business
March 11, 2025
·
4 min read
Press Releases
Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with Three New Concentrations
September 23, 2025
·
7 min read
Press Releases
Endo Announces Nine New and Modified Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
October 9, 2025
·
10 min read
1 of 31,186
Next
